Log in
NASDAQ:AWH

Aspira Women's Health Stock Forecast, Price & News

$3.75
+0.07 (+1.90 %)
(As of 10/20/2020 12:00 AM ET)
Add
Compare
Today's Range
$3.66
Now: $3.75
$3.76
50-Day Range N/A
52-Week Range
$0.51
Now: $3.75
$5.78
Volume628,584 shs
Average Volume615,650 shs
Market Capitalization$390.10 million
P/E RatioN/A
Dividend YieldN/A
Beta3.2
Aspira Women's Health Inc., together with its subsidiaries, discovers, develops, and commercializes diagnostic and bio-analytical solutions that help physicians to diagnose, treat, and enhance gynecologic health outcomes for women in the United States. The company provides sells OVA1, Overa, and Ova1PLUS risk of malignancy tests for ovarian cancer. It also offers ASPiRA GenetiX, a genetic test for specific women's health diseases. In addition, the company owns and operates ASPiRA LABS, a lab that specializes in applying biomarker-based technologies to address critical needs in the management of gynecologic cancers and disease. Further, it is developing diagnostic algorithms, as well as a high-risk screening algorithm for patients who are genetically predisposed to ovarian cancer. The company serves physicians, physician office laboratories, and hospital laboratories. The company was formerly known as Vermillion, Inc. and changed its name to Aspira Women's Health Inc. in June 2020. Aspira Women's Health Inc. was founded in 1993 and is headquartered in Austin, Texas.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.00 out of 5 stars

Industry, Sector and Symbol

Industry Diagnostic substances
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:AWH
CUSIPN/A
CIKN/A
Phone512-519-0400
Employees52

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$4.54 million
Book Value$0.09 per share

Profitability

Net Income$-15,240,000.00
Net Margins-323.40%

Miscellaneous

Market Cap$390.10 million
Next Earnings Date11/10/2020 (Estimated)
OptionableOptionable
$3.75
+0.07 (+1.90 %)
(As of 10/20/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive AWH News and Ratings via Email

Sign-up to receive the latest news and ratings for AWH and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Aspira Women's Health (NASDAQ:AWH) Frequently Asked Questions

Do Wall Street analysts recommend investors buy shares of Aspira Women's Health?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Aspira Women's Health in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Aspira Women's Health
.

When is Aspira Women's Health's next earnings date?

Aspira Women's Health is scheduled to release its next quarterly earnings announcement on Tuesday, November 10th 2020.
View our earnings forecast for Aspira Women's Health
.

How were Aspira Women's Health's earnings last quarter?

Aspira Women's Health Inc. (NASDAQ:AWH) issued its earnings results on Thursday, August, 13th. The company reported ($0.04) earnings per share for the quarter. The company had revenue of $0.75 million for the quarter. Aspira Women's Health had a negative return on equity of 177.99% and a negative net margin of 323.40%.
View Aspira Women's Health's earnings history
.

Who are some of Aspira Women's Health's key competitors?

What other stocks do shareholders of Aspira Women's Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Aspira Women's Health investors own include AcelRx Pharmaceuticals (ACRX), Aptinyx (APTX), Axcella Health (AXLA), Aytu BioScience (AYTU), Calithera Biosciences (CALA), Cidara Therapeutics (CDTX), Catalyst Pharmaceuticals (CPRX), DURECT (DRRX), Geron (GERN) and LiveXLive Media (LIVX).

Who are Aspira Women's Health's key executives?

Aspira Women's Health's management team includes the following people:
  • Ms. Valerie Barber Palmieri, CEO, Pres & Director (Age 59, Pay $544.43k)
  • Mr. Robert Harry Beechey CPA, Chief Financial Officer (Age 57, Pay $364.68k)
  • Dr. Lesley Northrop Ph.D., Global Medical Director of Genetic Services

What is Aspira Women's Health's stock symbol?

Aspira Women's Health trades on the NASDAQ under the ticker symbol "AWH."

How do I buy shares of Aspira Women's Health?

Shares of AWH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Aspira Women's Health's stock price today?

One share of AWH stock can currently be purchased for approximately $3.75.

How big of a company is Aspira Women's Health?

Aspira Women's Health has a market capitalization of $390.10 million and generates $4.54 million in revenue each year. The company earns $-15,240,000.00 in net income (profit) each year or ($0.18) on an earnings per share basis. Aspira Women's Health employs 52 workers across the globe.

What is Aspira Women's Health's official website?

The official website for Aspira Women's Health is www.aspirawh.com.

How can I contact Aspira Women's Health?

Aspira Women's Health's mailing address is 12117 BEE CAVES ROAD BUILDING THREE SUITE 100, AUSTIN TX, 78738. The company can be reached via phone at 512-519-0400 or via email at [email protected]

This page was last updated on 10/21/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.